We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Nanomedical Applications Global Market Worth $3.8 Billion by 2013

By LabMedica International staff writers
Posted on 03 Oct 2008
Print article
According to a new technical market research report, the global medical market for nanotechnology applications generated US$1.7 billion in 2007. This is expected to increase to $1.9 billion in 2008, and $3.8 billion in 2013 for a compound annual growth rate (CAGR) of 14.9%. Furthermore, this market has the potential to reach $9.4 billion in 2018 at a CAGR of 19.9%.

According to BCC Research (Wellesley, MA, USA), a marketing research company, the market is broken down into the categories of nanoparticles, other nanostructured materials, and nanotools/nanodevices. Of these, the nanoparticles segment has the largest share of the market. Valued at $1.6 billion in 2007, this segment should increase at a CAGR of 13.4% to reach $1.8 billion in 2008 and $3.4 billion in 2013. Nanoparticles could potentially see $7.9 billion in revenue in 2018 with a CAGR of 18.6%.

Other nanostructured materials represent the next largest, and fastest growing, segment. Nanostructured materials generated $36.5 million in 2007 and an estimated $45.1 million in 2008. This should increase to $304.7 million in 2013 for a CAGR of 46.5%. This segment has the potential to reach $1.1 billion in 2018 at a CAGR of 29.4%.

Nanotools and nanodevices have the smallest share of the market, worth $30.5 million in 2007. This is expected to grow at a CAGR of 17.8% to reach $34.2 million in 2008 and $77.6 million in 2013. There is a potential for this segment to generate $287.5 million in 2018 at a CAGR of 29.9%.

Pharmaceutical applications currently dominate the market, according to BCC, accounting for nearly 90% of revenue in 2007, and this trend is expected to continue through 2008. This segment is expected to decrease to less than 70% of the market by 2013 and potentially near 50% of the market by 2018. Nanotechnology applications for medical research and medical devices are both expected to significantly gain in market share, potentially reaching 20% each by 2018.

BCC's market analysis delivers market research reports, newsletters, and conferences that provide companies with the insights needed to make intelligent and strategic business decisions.

Related Links:
BCC Research


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Collection Container
Urine Monovette
New
Flow Cytometer
BF – 710

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Small molecule modulation of protein corona significantly enhances deep plasma proteome profiling (Photo courtesy of Mahmoudi Group)

Smarter Blood Tests Deliver Faster Diagnoses and Improved Outcomes

It has long been established that the earlier a disease is detected, the better the chances for a positive patient outcome. A novel method now offers an in-depth analysis of proteins in plasma, uncovering... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)

New Imaging Technique Reduces Skin Tone Bias in Breast Cancer Detection

Breast cancer remains a significant global health issue, and early detection is key to successful treatment. Traditional imaging techniques like mammography often face challenges, particularly for women... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.